Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Silexion Therapeutics Corp - Ordinary Shares
(NQ:
SLXN
)
2.200
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silexion Therapeutics Corp - Ordinary Shares
< Previous
1
2
3
4
Next >
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
↗
January 28, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via
Chartmill
Why Is Silexion Therapeutics Stock Soaring Over 100% On Tuesday?
↗
January 28, 2025
Silexion Therapeutics shares preclinical data on SIL-204, highlighting tumor reduction in KRAS-driven cancers and sustained drug efficacy for 56+ days.
Via
Benzinga
Check out the stocks that are attracting the most attention and driving market activity.
↗
January 28, 2025
Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Via
Chartmill
Gold Gains 1%; Boeing Shares Rise Following Q4 Results
↗
January 28, 2025
Via
Benzinga
These stocks are moving in today's session
↗
January 28, 2025
Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results
↗
January 28, 2025
Via
Benzinga
The market is filled with gapping stocks in Tuesday's session.
↗
January 28, 2025
Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings
↗
January 28, 2025
Via
Benzinga
Topics
Stocks
Silexion Therapeutics Highlights New Preclinical Data From Its Pancreatic Cancer Studies
↗
January 16, 2025
Silexion Therapeutics' SIL-204 exhibits synergy with key pancreatic cancer drugs in preclinical studies. Phase 2/3 trials planned for 2026.
Via
Benzinga
PESG Market Update: Silexion Therapeutics’ SIL-204 Shows Groundbreaking Synergy in Preclinical Data, Boosting Hope for KRAS-Driven Cancer Treatments
January 16, 2025
From
PESG
Via
Business Wire
Silexion Stock Hits Record Intraday Low After Pricing $5M Offering, But Retail Excitement Over Cancer Data Endures
↗
January 16, 2025
Priced at $1.35 per share and warrant, the offering was below Wednesday’s closing price of $1.56.
Via
Stocktwits
Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
January 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
January 16, 2025
Via
Benzinga
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
↗
January 16, 2025
Via
Benzinga
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
↗
December 19, 2024
Via
Benzinga
PESG Releases Market Update: Silexion Therapeutics Advances KRAS-Targeting Therapies with New Collaboration As Industry Demand for Precision Oncology Solutions Rises
December 17, 2024
From
PESG Research
Via
Business Wire
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
↗
December 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 06, 2024
Via
Benzinga
Agilent, Bath & Body Works And 3 Stocks To Watch Heading Into Monday
↗
November 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 20, 2024
Via
Benzinga
What's Going On With Silexion Therapeutics Shares Wednesday?
↗
November 20, 2024
Silexion Therapeutics shares are moving higher on Wednesday after the company reported that Guangzhou Sino-Israel bio-industry investment fund holds a decent stake in the company.
Via
Benzinga
US Stocks Mostly Lower; Target Posts Downbeat Earnings
↗
November 20, 2024
Via
Benzinga
Ilan Hadar, CEO of Silexion Therapeutics Corp. (NASDAQ: SLXN), to Present at NobleCon20
November 14, 2024
Via
Investor Brand Network
Silexion Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 14, 2024
Significant advancements in clinical and preclinical programs targeting KRAS-driven cancers; company advancing pipeline with focus on challenging oncology indications.
Via
News Direct
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 23, 2024
Via
Benzinga
Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit
October 09, 2024
Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit
Via
News Direct
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 04, 2024
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
